NYSE:MMS - MAXIMUS Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$64.89 +0.06 (+0.09 %)
(As of 07/18/2018 04:00 PM ET)
Previous Close$64.83
Today's Range$64.34 - $64.94
52-Week Range$58.75 - $72.71
Volume167,607 shs
Average Volume438,785 shs
Market Capitalization$4.20 billion
P/E Ratio21.32
Dividend Yield0.28%
Beta1.12
MAXIMUS logoMAXIMUS, Inc. provides business process services (BPS) to government health and human services programs in the United States, the United Kingdom, Australia, Canada, Singapore, and Saudi Arabia. The company's Health Services segment offers various BPS, appeals, and assessments, as well as related consulting services for state, provincial, and national government programs comprising Medicaid, Children's Health Insurance Program, the Affordable Care Act, Health Insurance British Columbia, the Health Assessment Advisory Service, and Preadmission Screening and Resident Reviews. Its services include health insurance exchange customer contact center operations and support; health insurance program eligibility and enrollment; beneficiary outreach and education; application assistance and independent health plan enrollment counseling; premium payment processing and administration; eHealth solutions; independent disability, long-term sick, and health assessments; occupational health clinical assessments; and specialized program consulting services. The company's U.S. Federal Services segment offers services, including centralized customer contact centers and support services; documents and records management; and case management, citizen engagement, and consumer education; independent medical reviews and worker's compensation benefit appeals; health benefit appeals; eligibility appeals; modernization of systems and IT infrastructure; infrastructure operations and support; software development, operations, and management; and data analytics. Its Human Services segment provides national, state, and local human services agencies with various BPS and related consulting services for welfare-to-work, child support, and higher education; and management tools and professional consulting, program consulting, and tax credit and employer services. MAXIMUS, Inc. was founded in 1975 and is headquartered in Reston, Virginia.

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services
SectorBusiness Services
SymbolNYSE:MMS
CUSIP57793310
Phone703-251-8500

Debt

Debt-to-Equity RatioN/A
Current Ratio2.72
Quick Ratio2.72

Price-To-Earnings

Trailing P/E Ratio21.32
Forward P/E Ratio20.09
P/E Growth2.49

Sales & Book Value

Annual Sales$2.45 billion
Price / Sales1.73
Cash Flow$4.1650 per share
Price / Cash15.58
Book Value$14.59 per share
Price / Book4.45

Profitability

EPS (Most Recent Fiscal Year)$3.03
Net Income$209.42 million
Net Margins9.15%
Return on Equity21.67%
Return on Assets15.50%

Miscellaneous

Employees20,400
Outstanding Shares65,240,000
Market Cap$4,204.91

The Truth About Cryptocurrencies

MAXIMUS (NYSE:MMS) Frequently Asked Questions

What is MAXIMUS's stock symbol?

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?

MAXIMUS declared a quarterly dividend on Thursday, July 12th. Shareholders of record on Wednesday, August 15th will be given a dividend of $0.045 per share on Friday, August 31st. This represents a $0.18 annualized dividend and a yield of 0.28%. The ex-dividend date is Tuesday, August 14th. View MAXIMUS's Dividend History.

How will MAXIMUS's stock buyback program work?

MAXIMUS declared that its Board of Directors has authorized a share buyback plan on Monday, June 25th 2018, which allows the company to repurchase $200,000,000.00 in shares, according to EventVestor. This repurchase authorization allows the company to purchase up to 4.9% of its stock through open market purchases. Stock repurchase plans are usually an indication that the company's board of directors believes its shares are undervalued.

How were MAXIMUS's earnings last quarter?

MAXIMUS, Inc. (NYSE:MMS) issued its quarterly earnings results on Thursday, May, 10th. The health services provider reported $0.82 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.84 by $0.02. The health services provider earned $612.79 million during the quarter, compared to analysts' expectations of $617.97 million. MAXIMUS had a return on equity of 21.67% and a net margin of 9.15%. The firm's revenue for the quarter was down 1.5% on a year-over-year basis. During the same period last year, the company posted $0.80 earnings per share. View MAXIMUS's Earnings History.

What guidance has MAXIMUS issued on next quarter's earnings?

MAXIMUS issued an update on its FY18 earnings guidance on Thursday, May, 10th. The company provided EPS guidance of $3.30-3.40 for the period, compared to the Thomson Reuters consensus estimate of $3.49. The company issued revenue guidance of $2.4-2.44 billion, compared to the consensus revenue estimate of $2.50 billion.

What price target have analysts set for MMS?

3 brokers have issued 12 month price targets for MAXIMUS's stock. Their forecasts range from $64.00 to $81.00. On average, they expect MAXIMUS's stock price to reach $69.50 in the next year. This suggests a possible upside of 7.1% from the stock's current price. View Analyst Ratings for MAXIMUS.

What is the consensus analysts' recommendation for MAXIMUS?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 3 hold ratings for the stock, resulting in a consensus recommendation of "Hold."

Who are some of MAXIMUS's key competitors?

Who are MAXIMUS's key executives?

MAXIMUS's management team includes the folowing people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 51)
  • Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 66)
  • Mr. Richard J. Nadeau, CFO & Treasurer (Age 63)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 57)
  • Mr. Mark S. Andrekovich, Chief of Human Capital and Pres of Tax & Employer Services (Age 56)

Has MAXIMUS been receiving favorable news coverage?

Media headlines about MMS stock have trended somewhat positive recently, Accern Sentiment reports. Accern rates the sentiment of media coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. MAXIMUS earned a coverage optimism score of 0.24 on Accern's scale. They also assigned headlines about the health services provider an impact score of 48.05 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are MAXIMUS's major shareholders?

MAXIMUS's stock is owned by many different of institutional and retail investors. Top institutional investors include Riverbridge Partners LLC (1.55%), Handelsbanken Fonder AB (0.48%), Summit Creek Advisors LLC (0.25%), West Coast Financial LLC (0.14%), Contravisory Investment Management Inc. (0.11%) and Cambiar Investors LLC (0.11%). Company insiders that own MAXIMUS stock include Anne K Altman, Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Richard John Nadeau and Russell A Beliveau. View Institutional Ownership Trends for MAXIMUS.

Which major investors are selling MAXIMUS stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Riverbridge Partners LLC, Summit Creek Advisors LLC, Clinton Group Inc., Bank of Montreal Can, West Coast Financial LLC and Contravisory Investment Management Inc.. Company insiders that have sold MAXIMUS company stock in the last year include Bruce Caswell, David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni and Russell A Beliveau. View Insider Buying and Selling for MAXIMUS.

Which major investors are buying MAXIMUS stock?

MMS stock was bought by a variety of institutional investors in the last quarter, including Cambiar Investors LLC, Xact Kapitalforvaltning AB and Cim LLC. Company insiders that have bought MAXIMUS stock in the last two years include Anne K Altman and Richard John Nadeau. View Insider Buying and Selling for MAXIMUS.

How do I buy shares of MAXIMUS?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is MAXIMUS's stock price today?

One share of MMS stock can currently be purchased for approximately $64.89.

How big of a company is MAXIMUS?

MAXIMUS has a market capitalization of $4.20 billion and generates $2.45 billion in revenue each year. The health services provider earns $209.42 million in net income (profit) each year or $3.03 on an earnings per share basis. MAXIMUS employs 20,400 workers across the globe.

How can I contact MAXIMUS?

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]


MarketBeat Community Rating for MAXIMUS (NYSE MMS)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  334 (Vote Outperform)
Underperform Votes:  308 (Vote Underperform)
Total Votes:  642
MarketBeat's community ratings are surveys of what our community members think about MAXIMUS and other stocks. Vote "Outperform" if you believe MMS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MMS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/18/2018 by MarketBeat.com Staff

Featured Article: Earnings Per Share

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.